| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |